title: Sandimmun neoral improves the bioavailability of cyclosporin A and decreases inter-individual variations in patients affected with cystic fibrosis.
authors.affiliation: Sandoz Laboratories Rueil Malmaison, France.
authors.forename: D
authors.initials: D
authors.lastname: Girault
authors.forename: A
authors.initials: A
authors.lastname: Haloun
authors.forename: L
authors.initials: L
authors.lastname: Viard
authors.forename: G
authors.initials: G
authors.lastname: Bellon
authors.forename: F
authors.initials: F
authors.lastname: Gottrand
authors.forename: R
authors.initials: R
authors.lastname: Guillemain
authors.forename: G
authors.initials: G
authors.lastname: Lenoir
authors.forename: F L
authors.initials: FL
authors.lastname: Ladurie
authors.forename: E
authors.initials: E
authors.lastname: Plouvier
authors.forename: V
authors.initials: V
authors.lastname: Storni
mesh_terms: D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D001379:Azathioprine / Q000627:therapeutic use; D001682:Biological Availability; D002648:Child; D016572:Cyclosporine / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics*; D003550:Cystic Fibrosis / Q000378:metabolism / Q000601:surgery*; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D016041:Heart-Lung Transplantation / Q000276:immunology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology*; D016031:Liver Transplantation / Q000276:immunology*; D016040:Lung Transplantation / Q000276:immunology*; D008297:Male; D008657:Metabolic Clearance Rate; D013256:Steroids / Q000627:therapeutic use; D013997:Time Factors
chemical_list: D007166:Immunosuppressive Agents; D013256:Steroids; D016572:Cyclosporine; D001379:Azathioprine